Inspire Medical Systems, Inc.

NYSE:INSP Lagerbericht

Marktkapitalisierung: US$6.3b

Inspire Medical Systems Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Inspire Medical Systems wird ein jährliches Gewinn- und Umsatzwachstum von 53.1% bzw. 17.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 53% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 3.9% betragen.

Wichtige Informationen

44.9%

Wachstumsrate der Gewinne

44.2%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum17.6%
Wachstumsrate der Einnahmen16.7%
Zukünftige Eigenkapitalrendite7.0%
Analystenabdeckung

Good

Zuletzt aktualisiert12 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Aug 08
After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

Jul 17
Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Jun 22
At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

May 09
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Dec 26
Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Inspire Medical Systems: Time To Wake Up

Nov 17

An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Nov 13
An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Sep 05
When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Aug 10
Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Jul 16
Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

May 06
Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

Inspire Medical stock rises after guiding revenue above estimates

Jan 09

Inspire Medical nears eight-month high as KeyBanc issues bullish call

Dec 13

Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy

Oct 26

Inspire Medical Systems: Sleep Apnea Value Delivery Pocket

Oct 13

Gewinn- und Umsatzwachstumsprognosen

NYSE:INSP - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20261,1338515019712
12/31/20259504211813617
12/31/20247952310910517
6/30/20247066-930N/A
3/31/2024661-16335N/A
12/31/2023625-21125N/A
9/30/2023570-33827N/A
6/30/2023526-411934N/A
3/31/2023466-441123N/A
12/31/2022408-45212N/A
9/30/2022348-50-14-7N/A
6/30/2022301-44-23-18N/A
3/31/2022262-43-27-22N/A
12/31/2021233-42-25-20N/A
9/30/2021201-47-30-25N/A
6/30/2021175-47-38-34N/A
3/31/2021134-57-52-49N/A
12/31/2020115-57-55-53N/A
9/30/202096-59-57-55N/A
6/30/202081-57-51-49N/A
3/31/202087-41-39-37N/A
12/31/201982-33-36-33N/A
9/30/201972-29-32-29N/A
6/30/201964-25-31-30N/A
3/31/201957-24-24-23N/A
12/31/201851-22-19-19N/A
9/30/201844-21-20-19N/A
6/30/201838-21-19-19N/A
3/31/201833-20N/A-17N/A
12/31/201729-18N/A-16N/A
12/31/201616-19N/A-18N/A
12/31/20158-21N/A-22N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: INSPDas prognostizierte Gewinnwachstum (45.6% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: INSPDie Erträge des Unternehmens (45.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.9% pro Jahr).

Hohe Wachstumserträge: INSPEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: INSPDie Einnahmen des Unternehmens (17.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: INSPDie Einnahmen des Unternehmens (17.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: INSPDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (3.9%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y